L
LiliPeptide
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| BPC-157 | C | 12 | 7.1 | 4.1 | 10.0 | 25 Sep 2025 |
| GHK-Cu | C | 17 | 6.4 | 4.6 | 8.0 | 25 Sep 2025 |
| Ipamorelin | D | 7 | 7.6 | 3.5 | 10.0 | 25 Sep 2025 |
| TB-500 | D | 6 | 6.3 | 3.6 | 9.2 | 9 Sep 2025 |
| Retatrutide | E | 101 | 7.9 | 0.0 | 10.0 | 4 Aug 2025 |
| PT-141 | E | 7 | 5.8 | 0.0 | 8.4 | 25 Sep 2025 |
| Tesamorelin | E | 10 | 5.9 | 0.0 | 10.0 | 17 Nov 2025 |
| Tirzepatide | E | 25 | 7.1 | 0.0 | 10.0 | 1 Sep 2025 |
| 5-amino-1MQ | C | 10 | 7.1 | 4.9 | 9.6 | 21 May 2026 |
| AA Water | C | 10 | 6.5 | 4.2 | 9.1 | 24 May 2026 |
| Adamax | C | 14 | 7.1 | 5.4 | 9.3 | 17 May 2026 |
| Adipotide | C | 6 | 8.3 | 5.9 | 10.0 | 25 May 2026 |
| Aromasin (Exemestane) | C | 8 | 7.0 | 3.8 | 10.0 | 25 May 2026 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | C | 3 | 7.7 | 5.6 | 10.0 | 24 May 2026 |
| BMK methyl glycidate CAS 80532-66-7 | C | 15 | 8.1 | 6.4 | 10.0 | 21 May 2026 |
| Boldenone Cypionate | C | 12 | 8.0 | 4.9 | 10.0 | 23 May 2026 |
| Botulinum toxin | C | 4 | 8.8 | 7.5 | 9.8 | 25 May 2026 |
| CJC-1295 With DAC | C | 10 | 7.6 | 5.8 | 9.7 | 24 May 2026 |
| Crystagen | C | 13 | 7.8 | 5.1 | 9.8 | 26 Jan 2026 |
| Dermorphin | C | 2 | 7.6 | 7.4 | 7.8 | 26 Jan 2026 |
| Dianabol Oil | X | 1 | 5.8 | 5.8 | 5.8 | 28 Mar 2025 |
| Estradiol Cypionate | C | 13 | 7.4 | 5.5 | 9.9 | 24 May 2026 |
| GHRP-6 Acetate | C | 8 | 7.7 | 6.1 | 10.0 | 17 May 2026 |
| HGH 191AA (Somatropin) | C | 2 | 7.7 | 6.7 | 8.7 | 24 May 2026 |
| HGH Fragment 176-191 | C | 3 | 7.3 | 6.1 | 9.2 | 23 May 2026 |
| Humanin | C | 4 | 7.9 | 6.6 | 9.3 | 21 May 2026 |
| Ivermectin | C | 9 | 7.1 | 4.2 | 10.0 | 23 May 2026 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | C | 8 | 8.0 | 6.3 | 10.0 | 24 May 2026 |
| KPV Oral | X | 1 | 7.4 | 7.4 | 7.4 | 25 Apr 2025 |
| KPV | C | 2 | 7.5 | 7.1 | 8.0 | 19 Jan 2026 |
| Letrozole | C | 15 | 6.5 | 4.0 | 10.0 | 19 Jan 2026 |
| Methylene Blue | C | 13 | 7.2 | 2.9 | 10.0 | 19 Jan 2026 |
| MGF | C | 4 | 6.6 | 6.3 | 6.9 | 17 May 2026 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | C | 11 | 7.1 | 5.9 | 9.1 | 24 May 2026 |
| Oxytocin Acetate | C | 2 | 8.2 | 7.8 | 8.5 | 21 May 2026 |
| Phenylacetic acid CAS 103-82-2 | C | 13 | 6.7 | 4.6 | 8.9 | 17 May 2026 |
| Prostamax | C | 12 | 7.5 | 4.4 | 10.0 | 23 May 2026 |
| Semaglutide Oral | C | 6 | 6.7 | 4.1 | 9.3 | 26 Jan 2026 |
| Sustanon 250 | C | 15 | 7.6 | 4.3 | 10.0 | 21 May 2026 |
| Tesamorelin 11mg + Ipamorelin 6mg Blend | C | 9 | 6.4 | 3.6 | 8.8 | 24 May 2026 |
| Test Suspension | C | 2 | 8.2 | 7.9 | 8.4 | 17 May 2026 |
| Thymosin Alpha-1 | C | 7 | 8.1 | 6.4 | 10.0 | 25 May 2026 |
| Tirzepatide Oral | C | 7 | 7.1 | 5.3 | 10.0 | 25 May 2026 |
| Turinabol | C | 7 | 7.8 | 5.0 | 10.0 | 17 May 2026 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | 5-amino-1MQ | 7.3 | 5mg | 6.2mg | +23.4% | 99.76% | Lab C |
| 25 May 2026 | AA Water | 7.1 | 50mg | 45.7mg | -8.6% | 97.55% | Lab E |
| 25 May 2026 | Adamax | 7.8 | 20mg | 17.6mg | -11.8% | 96.98% | Lab F |
| 25 May 2026 | Adamax | 6.9 | 5mg | 5.3mg | +5.9% | 95.99% | Lab A |
| 25 May 2026 | Botulinum toxin | 9.6 | 2mg | 2.1mg | +6.1% | 98.88% | Lab F |
| 25 May 2026 | Semaglutide Oral | 6.3 | 100mg | 90.9mg | -9.1% | 96.69% | Lab A |
| 25 May 2026 | Semaglutide Oral | 6.9 | 100mg | 122.9mg | +22.9% | 98.61% | Lab E |
| 25 May 2026 | Sustanon 250 | 5.9 | 300mg/ml | 309.5mg/ml | +3.2% | 96.75% | Lab C |
| 25 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 7.2 | 10mg | 8.8mg | -11.8% | 96.15% | Lab A |
| 24 May 2026 | AA Water | 8.2 | 50mg | 47.0mg | -6.1% | 98.07% | Lab G |
| 24 May 2026 | AA Water | 6.1 | 50mg | 51.6mg | +3.2% | 98.43% | Lab C |
| 24 May 2026 | Aromasin (Exemestane) | 5.0 | 50mg | 48.8mg | -2.5% | 95.41% | Lab D |
| 24 May 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 7.1 | 250mg/ml | 283.2mg/ml | +13.3% | 99.85% | Lab F |
| 24 May 2026 | Dermorphin | 8.1 | 10mg | 8.8mg | -11.6% | 95.89% | Lab G |
| 24 May 2026 | Estradiol Cypionate | 7.7 | 250mg/ml | 242.6mg/ml | -3.0% | 95.25% | Lab D |
| 24 May 2026 | Estradiol Cypionate | 7.0 | 250mg/ml | 239.4mg/ml | -4.2% | 96.67% | Lab D |
| 24 May 2026 | Humanin | 6.6 | 20mg | 23.9mg | +19.3% | 96.98% | Lab C |
| 24 May 2026 | Ivermectin | 5.7 | 50mg | 52.3mg | +4.6% | 95.48% | Lab B |
| 24 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 8.8 | 2mg | 1.9mg | -7.5% | 97.17% | Lab A |
| 24 May 2026 | Letrozole | 7.0 | 100mg | 103.6mg | +3.6% | 96.23% | Lab C |
| 24 May 2026 | Methylene Blue | 7.4 | 10mg | 11.8mg | +18.3% | 98.98% | Lab B |
| 24 May 2026 | Prostamax | 4.0 | 10mg | 9.3mg | -6.8% | 96.60% | Lab G |
| 24 May 2026 | Sustanon 250 | 9.7 | 200mg/ml | 183.6mg/ml | -8.2% | 95.94% | Lab F |
| 24 May 2026 | Sustanon 250 | 6.4 | 100mg/ml | 88.6mg/ml | -11.4% | 97.87% | Lab D |
| 24 May 2026 | Sustanon 250 | 8.1 | 100mg/ml | 96.9mg/ml | -3.1% | 96.64% | Lab G |
| 24 May 2026 | Thymosin Alpha-1 | 8.4 | 15mg | 15.5mg | +3.4% | 95.85% | Lab D |
| 24 May 2026 | Tirzepatide | 8.6 | 30mg | 32.9mg | +9.7% | 99.90% | Lab E |
| 24 May 2026 | AA Water | 6.7 | 2mg | 1.9mg | -2.7% | 98.09% | Lab E |
| 24 May 2026 | Adamax | 8.3 | 30mg | 33.6mg | +12.0% | 96.26% | Lab F |
| 24 May 2026 | Boldenone Cypionate | 6.5 | 300mg/ml | 309.6mg/ml | +3.2% | 95.79% | Lab D |
| 24 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.3 | 2mg | 2.2mg | +10.9% | 95.71% | Lab G |
| 24 May 2026 | Letrozole | 5.6 | 20mg | 17.8mg | -11.1% | 97.03% | Lab F |
| 24 May 2026 | Phenylacetic acid CAS 103-82-2 | 7.1 | 5g | 5.2g | +3.4% | 96.46% | Lab G |
| 24 May 2026 | Prostamax | 7.3 | 15mg | 17.1mg | +14.1% | 97.34% | Lab B |
| 24 May 2026 | Prostamax | 6.2 | 10mg | 12.1mg | +21.5% | 96.26% | Lab D |
| 24 May 2026 | Semaglutide Oral | 6.5 | 100mg | 118.8mg | +18.8% | 98.95% | Lab D |
| 24 May 2026 | Retatrutide | 5.7 | 40mg | 38.2mg | -4.5% | 98.66% | Lab E |
| 24 May 2026 | Retatrutide | 8.4 | 20mg | 19.8mg | -1.0% | 99.20% | Lab E |
| 24 May 2026 | Retatrutide | 10.0 | 15mg | 15.1mg | +0.7% | 99.90% | Lab E |
| 24 May 2026 | Retatrutide | 7.7 | 60mg | 59.4mg | -1.0% | 98.65% | Lab E |
| 24 May 2026 | Retatrutide | 6.1 | 10mg | 9.59mg | -4.1% | 99.06% | Lab E |
| 24 May 2026 | Adamax | 6.6 | 2mg | 1.9mg | -4.4% | 98.55% | Lab C |
| 24 May 2026 | Botulinum toxin | 8.4 | 2mg | 2.1mg | +5.5% | 99.37% | Lab A |
| 24 May 2026 | GHRP-6 Acetate | 9.9 | 5mg | 5.7mg | +13.7% | 98.48% | Lab A |
| 24 May 2026 | GHRP-6 Acetate | 8.5 | 50mg | 49.3mg | -1.4% | 97.04% | Lab G |
| 24 May 2026 | Ivermectin | 8.5 | 10mg | 11.0mg | +10.5% | 95.93% | Lab A |
| 24 May 2026 | Letrozole | 6.1 | 10mg | 9.9mg | -0.5% | 96.54% | Lab G |
| 24 May 2026 | Methylene Blue | 5.8 | 25mg | 23.0mg | -8.1% | 98.03% | Lab F |
| 24 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 4.0 | 20mg | 17.3mg | -13.5% | 99.12% | Lab A |
| 24 May 2026 | Prostamax | 7.8 | 5mg | 5.4mg | +7.5% | 97.15% | Lab A |
| 24 May 2026 | Tirzepatide Oral | 7.7 | 20mg | 23.1mg | +15.7% | 98.76% | Lab F |
| 24 May 2026 | Adipotide | 7.5 | 5mg | 4.9mg | -1.7% | 98.32% | Lab D |
| 24 May 2026 | Estradiol Cypionate | 7.3 | 300mg/ml | 368.0mg/ml | +22.7% | 96.23% | Lab G |
| 24 May 2026 | Ivermectin | 7.9 | 25mg | 27.5mg | +10.2% | 97.22% | Lab A |
| 24 May 2026 | Letrozole | 6.0 | 50mg | 57.2mg | +14.4% | 98.29% | Lab G |
| 24 May 2026 | Methylene Blue | 6.9 | 20mg | 22.9mg | +14.7% | 95.37% | Lab E |
| 24 May 2026 | Methylene Blue | 8.8 | 10mg | 11.0mg | +10.2% | 95.62% | Lab G |
| 24 May 2026 | MGF | 7.5 | 2mg | 2.5mg | +24.4% | 96.23% | Lab B |
| 24 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 6.3 | 30mg | 32.9mg | +9.6% | 95.87% | Lab D |
| 24 May 2026 | GHK-Cu | 6.7 | 100mg | 93.4mg | -6.6% | 99.60% | Lab G |
| 24 May 2026 | 5-amino-1MQ | 7.8 | 20mg | 22.3mg | +11.3% | 98.47% | Lab D |
| 24 May 2026 | Adamax | 7.1 | 2mg | 1.8mg | -10.2% | 99.60% | Lab D |
| 24 May 2026 | Crystagen | 8.4 | 30mg | 36.7mg | +22.4% | 98.17% | Lab A |
| 24 May 2026 | Dianabol Oil | 6.2 | 200mg/ml | 229.5mg/ml | +14.8% | 98.54% | Lab A |
| 24 May 2026 | Estradiol Cypionate | 5.5 | 100mg/ml | 121.1mg/ml | +21.1% | 97.87% | Lab G |
| 24 May 2026 | Ivermectin | 6.1 | 20mg | 23.6mg | +17.9% | 96.95% | Lab D |
| 24 May 2026 | Ivermectin | 6.0 | 20mg | 23.3mg | +16.4% | 95.61% | Lab B |
| 24 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.7 | 10mg | 10.4mg | +4.4% | 96.74% | Lab E |
| 24 May 2026 | Prostamax | 9.9 | 30mg | 29.2mg | -2.7% | 95.24% | Lab E |
| 24 May 2026 | Tirzepatide Oral | 7.1 | 50mg | 61.1mg | +22.2% | 99.08% | Lab G |
| 23 May 2026 | Boldenone Cypionate | 9.7 | 200mg/ml | 226.6mg/ml | +13.3% | 99.23% | Lab G |
| 23 May 2026 | Dermorphin | 6.7 | 10mg | 10.0mg | -0.2% | 98.14% | Lab D |
| 23 May 2026 | Letrozole | 8.9 | 100mg | 119.9mg | +19.9% | 95.42% | Lab A |
| 23 May 2026 | Sustanon 250 | 8.0 | 250mg/ml | 223.9mg/ml | -10.4% | 97.56% | Lab D |
| 23 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 6.3 | 50mg | 54.7mg | +9.3% | 99.51% | Lab A |
| 23 May 2026 | Thymosin Alpha-1 | 7.5 | 5mg | 4.5mg | -10.4% | 98.86% | Lab B |
| 23 May 2026 | 5-amino-1MQ | 7.5 | 5mg | 4.9mg | -1.2% | 99.97% | Lab A |
| 23 May 2026 | BMK methyl glycidate CAS 80532-66-7 | 9.7 | 10g | 11.9g | +18.8% | 97.49% | Lab D |
| 23 May 2026 | BMK methyl glycidate CAS 80532-66-7 | 7.3 | 1g | 1.1g | +8.7% | 99.00% | Lab D |
| 23 May 2026 | Humanin | 7.8 | 10mg | 11.8mg | +18.0% | 99.12% | Lab D |
| 23 May 2026 | Ivermectin | 7.2 | 50mg | 56.4mg | +12.9% | 97.22% | Lab B |
| 23 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 8.9 | 15mg | 15.2mg | +1.0% | 95.58% | Lab G |
| 23 May 2026 | Letrozole | 7.2 | 25mg | 29.3mg | +17.1% | 98.93% | Lab E |
| 23 May 2026 | Tirzepatide Oral | 7.7 | 10mg | 12.5mg | +24.9% | 96.52% | Lab D |
| 21 May 2026 | Adipotide | 6.8 | 5mg | 4.8mg | -4.0% | 96.16% | Lab D |
| 21 May 2026 | BMK methyl glycidate CAS 80532-66-7 | 8.0 | 500g | 582.2g | +16.4% | 98.67% | Lab G |
| 21 May 2026 | BMK methyl glycidate CAS 80532-66-7 | 8.0 | 100g | 121.3g | +21.3% | 97.13% | Lab G |
| 21 May 2026 | Prostamax | 8.7 | 5mg | 5.2mg | +5.0% | 97.89% | Lab E |
| 21 May 2026 | Thymosin Alpha-1 | 9.1 | 10mg | 12.0mg | +20.1% | 98.46% | Lab C |
| 21 May 2026 | Aromasin (Exemestane) | 4.7 | 50mg | 55.3mg | +10.6% | 99.88% | Lab B |
| 21 May 2026 | BMK methyl glycidate CAS 80532-66-7 | 7.9 | 10g | 8.6g | -13.6% | 99.12% | Lab D |
| 21 May 2026 | CJC-1295 With DAC | 5.5 | 2mg | 2.2mg | +10.6% | 97.99% | Lab D |
| 21 May 2026 | Crystagen | 8.9 | 10mg | 11.5mg | +14.6% | 95.32% | Lab A |
| 21 May 2026 | GHRP-6 Acetate | 7.8 | 15mg | 18.0mg | +19.7% | 97.02% | Lab C |
| 21 May 2026 | Humanin | 8.9 | 20mg | 17.9mg | -10.5% | 97.89% | Lab A |
| 21 May 2026 | Letrozole | 8.0 | 100mg | 87.6mg | -12.4% | 99.20% | Lab E |
| 21 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 8.7 | 10mg | 11.9mg | +18.8% | 97.34% | Lab F |
| 21 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 7.6 | 5mg | 5.5mg | +9.5% | 99.47% | Lab A |
| 21 May 2026 | Tirzepatide Oral | 8.0 | 25mg | 27.8mg | +11.4% | 99.39% | Lab E |
| 20 May 2026 | Adipotide | 9.0 | 30mg | 30.6mg | +1.9% | 99.32% | Lab A |
| 20 May 2026 | Boldenone Cypionate | 6.5 | 200mg/ml | 174.5mg/ml | -12.7% | 97.41% | Lab E |
| 20 May 2026 | GHRP-6 Acetate | 7.7 | 15mg | 13.8mg | -8.3% | 98.34% | Lab B |
| 20 May 2026 | KPV | 8.1 | 15mg | 14.1mg | -6.2% | 96.90% | Lab F |
| 20 May 2026 | Methylene Blue | 8.9 | 50mg | 43.8mg | -12.4% | 97.25% | Lab E |
| 20 May 2026 | Phenylacetic acid CAS 103-82-2 | 5.9 | 100g | 100.6g | +0.6% | 99.64% | Lab D |
| 20 May 2026 | Sustanon 250 | 7.3 | 300mg/ml | 287.9mg/ml | -4.0% | 99.39% | Lab B |
| 19 May 2026 | BMK methyl glycidate CAS 80532-66-7 | 8.7 | 5g | 5.9g | +18.1% | 98.47% | Lab D |
| 19 May 2026 | Boldenone Cypionate | 7.3 | 200mg/ml | 200.8mg/ml | +0.4% | 97.41% | Lab E |
| 19 May 2026 | Crystagen | 6.9 | 5mg | 6.1mg | +21.2% | 98.45% | Lab F |
| 19 May 2026 | GHRP-6 Acetate | 8.9 | 10mg | 9.1mg | -8.6% | 98.20% | Lab C |
| 19 May 2026 | HGH Fragment 176-191 | 7.7 | 30mg | 34.4mg | +14.5% | 99.85% | Lab D |
| 19 May 2026 | Ivermectin | 5.3 | 100mg | 119.0mg | +19.0% | 96.77% | Lab C |
| 19 May 2026 | Letrozole | 6.0 | 25mg | 27.7mg | +10.7% | 98.21% | Lab G |
| 19 May 2026 | Letrozole | 7.1 | 25mg | 29.7mg | +18.7% | 95.01% | Lab G |
| 19 May 2026 | Methylene Blue | 7.3 | 25mg | 29.7mg | +18.7% | 95.61% | Lab G |
| 19 May 2026 | MGF | 5.9 | 5mg | 5.3mg | +5.3% | 99.31% | Lab C |
| 19 May 2026 | MGF | 6.9 | 2mg | 1.9mg | -5.9% | 98.06% | Lab G |
| 19 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.6 | 5mg | 5.9mg | +18.4% | 99.59% | Lab A |
| 19 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 9.2 | 50mg | 56.9mg | +13.8% | 96.55% | Lab E |
| 17 May 2026 | Adamax | 9.2 | 15mg | 15.9mg | +6.2% | 98.37% | Lab A |
| 17 May 2026 | Aromasin (Exemestane) | 5.9 | 10mg | 11.2mg | +12.0% | 96.64% | Lab C |
| 17 May 2026 | BMK methyl glycidate CAS 80532-66-7 | 7.9 | 1g | 1.0g | -2.6% | 99.76% | Lab A |
| 17 May 2026 | Crystagen | 5.6 | 30mg | 34.7mg | +15.8% | 97.97% | Lab G |
| 17 May 2026 | Letrozole | 6.9 | 10mg | 11.2mg | +12.0% | 99.62% | Lab G |
| 17 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 8.2 | 5mg | 5.4mg | +7.3% | 98.12% | Lab F |
| 17 May 2026 | Oxytocin Acetate | 7.0 | 30mg | 28.1mg | -6.4% | 97.52% | Lab E |
| 17 May 2026 | Phenylacetic acid CAS 103-82-2 | 8.2 | 100g | 115.9g | +15.9% | 96.55% | Lab C |
| 17 May 2026 | Semaglutide Oral | 8.2 | 20mg | 19.9mg | -0.3% | 98.02% | Lab A |
| 17 May 2026 | Thymosin Alpha-1 | 5.7 | 30mg | 34.6mg | +15.5% | 95.05% | Lab F |
| 17 May 2026 | Tirzepatide Oral | 6.9 | 10mg | 9.8mg | -2.2% | 96.20% | Lab E |
| 29 Jan 2026 | 5-amino-1MQ | 6.9 | 10mg | 10.5mg | +4.7% | 98.79% | Lab F |
| 29 Jan 2026 | Aromasin (Exemestane) | 7.9 | 50mg | 43.9mg | -12.3% | 98.20% | Lab A |
| 29 Jan 2026 | Boldenone Cypionate | 8.1 | 200mg/ml | 236.6mg/ml | +18.3% | 97.37% | Lab E |
| 29 Jan 2026 | CJC-1295 With DAC | 6.5 | 2mg | 2.5mg | +24.7% | 97.00% | Lab G |
| 29 Jan 2026 | Methylene Blue | 5.2 | 50mg | 56.2mg | +12.4% | 97.62% | Lab B |
| 29 Jan 2026 | Oxytocin Acetate | 10.0 | 50mg | 62.2mg | +24.3% | 96.00% | Lab A |
| 29 Jan 2026 | Sustanon 250 | 8.5 | 250mg/ml | 223.1mg/ml | -10.8% | 95.54% | Lab B |
| 29 Jan 2026 | Turinabol | 6.0 | 50mg | 52.8mg | +5.6% | 99.06% | Lab E |
| 26 Jan 2026 | 5-amino-1MQ | 5.6 | 10mg | 9.9mg | -0.7% | 98.96% | Lab E |
| 26 Jan 2026 | Aromasin (Exemestane) | 8.6 | 100mg | 97.2mg | -2.8% | 96.51% | Lab G |
| 26 Jan 2026 | Boldenone Cypionate | 9.5 | 200mg/ml | 181.5mg/ml | -9.3% | 95.77% | Lab B |
| 26 Jan 2026 | Boldenone Cypionate | 7.1 | 250mg/ml | 276.3mg/ml | +10.5% | 99.09% | Lab F |
| 26 Jan 2026 | Crystagen | 9.4 | 15mg | 15.7mg | +4.5% | 99.59% | Lab A |
| 26 Jan 2026 | Phenylacetic acid CAS 103-82-2 | 4.0 | 100g | 91.2g | -8.8% | 96.42% | Lab C |
| 26 Jan 2026 | Phenylacetic acid CAS 103-82-2 | 7.4 | 1g | 1.1g | +5.2% | 97.30% | Lab A |
| 26 Jan 2026 | Phenylacetic acid CAS 103-82-2 | 8.2 | 10g | 10.7g | +6.9% | 95.58% | Lab C |
| 26 Jan 2026 | Sustanon 250 | 8.7 | 250mg/ml | 285.1mg/ml | +14.1% | 99.34% | Lab F |
| 26 Jan 2026 | Sustanon 250 | 6.7 | 200mg/ml | 243.9mg/ml | +22.0% | 95.13% | Lab B |
| 26 Jan 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 5.4 | 15mg | 13.8mg | -7.8% | 96.52% | Lab F |
| 19 Jan 2026 | AA Water | 7.1 | 30mg | 36.0mg | +20.0% | 99.35% | Lab F |
| 19 Jan 2026 | BMK methyl glycidate CAS 80532-66-7 | 7.5 | 10g | 11.4g | +13.9% | 96.63% | Lab G |
| 19 Jan 2026 | Botulinum toxin | 10.0 | 2mg | 1.8mg | -9.6% | 95.11% | Lab E |
| 19 Jan 2026 | Crystagen | 7.2 | 15mg | 12.8mg | -15.0% | 99.21% | Lab F |
| 19 Jan 2026 | Crystagen | 8.1 | 15mg | 15.6mg | +4.1% | 98.95% | Lab C |
| 19 Jan 2026 | Estradiol Cypionate | 8.0 | 250mg/ml | 240.3mg/ml | -3.9% | 99.63% | Lab E |
| 19 Jan 2026 | Estradiol Cypionate | 7.3 | 200mg/ml | 206.4mg/ml | +3.2% | 97.42% | Lab F |
| 19 Jan 2026 | Turinabol | 7.4 | 50mg | 53.6mg | +7.2% | 99.01% | Lab F |
| 19 Jan 2026 | Turinabol | 6.5 | 10mg | 12.4mg | +24.4% | 99.26% | Lab C |
| 9 Jan 2026 | 5-amino-1MQ | 5.4 | 50mg | 49.2mg | -1.5% | 97.33% | Lab B |
| 9 Jan 2026 | Adamax | 7.5 | 30mg | 30.3mg | +1.1% | 98.28% | Lab A |
| 9 Jan 2026 | GHRP-6 Acetate | 7.5 | 2mg | 2.1mg | +6.0% | 97.96% | Lab C |
| 9 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.7 | 5mg | 5.9mg | +17.1% | 97.83% | Lab A |
| 9 Jan 2026 | Methylene Blue | 6.7 | 50mg | 47.2mg | -5.6% | 98.01% | Lab A |
| 9 Jan 2026 | MGF | 7.0 | 20mg | 22.6mg | +12.8% | 98.89% | Lab C |
| 9 Jan 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 9.2 | 50mg | 47.0mg | -6.0% | 95.24% | Lab G |
| 9 Jan 2026 | Semaglutide Oral | 7.1 | 10mg | 8.9mg | -11.4% | 96.88% | Lab E |
| 9 Jan 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 4.5 | 2mg | 2.1mg | +5.4% | 97.63% | Lab F |
| 9 Jan 2026 | Thymosin Alpha-1 | 7.2 | 5mg | 5.7mg | +14.0% | 99.90% | Lab B |
| 9 Jan 2026 | Tirzepatide Oral | 9.9 | 25mg | 21.6mg | -13.6% | 99.37% | Lab D |
| 7 Jan 2026 | AA Water | 6.0 | 10mg | 10.6mg | +6.4% | 99.19% | Lab B |
| 7 Jan 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 7.1 | 250mg/ml | 282.2mg/ml | +12.9% | 98.73% | Lab B |
| 7 Jan 2026 | Crystagen | 7.9 | 2mg | 2.3mg | +16.4% | 96.44% | Lab C |
| 7 Jan 2026 | Crystagen | 9.0 | 30mg | 29.0mg | -3.5% | 96.06% | Lab B |
| 7 Jan 2026 | Sustanon 250 | 8.5 | 300mg/ml | 322.0mg/ml | +7.3% | 99.93% | Lab G |
| 7 Jan 2026 | Thymosin Alpha-1 | 10.0 | 50mg | 54.8mg | +9.7% | 99.52% | Lab F |
| 6 Jan 2026 | Boldenone Cypionate | 7.5 | 200mg/ml | 207.0mg/ml | +3.5% | 97.05% | Lab E |
| 6 Jan 2026 | CJC-1295 With DAC | 9.2 | 30mg | 35.2mg | +17.4% | 98.82% | Lab D |
| 6 Jan 2026 | CJC-1295 With DAC | 6.6 | 50mg | 50.6mg | +1.2% | 98.88% | Lab A |
| 6 Jan 2026 | Estradiol Cypionate | 7.4 | 300mg/ml | 338.1mg/ml | +12.7% | 97.60% | Lab E |
| 6 Jan 2026 | Humanin | 8.9 | 30mg | 29.5mg | -1.6% | 98.43% | Lab A |
| 6 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 7.0 | 20mg | 21.4mg | +6.9% | 99.51% | Lab G |
| 6 Jan 2026 | Letrozole | 6.0 | 100mg | 102.6mg | +2.6% | 98.92% | Lab C |
| 6 Jan 2026 | Methylene Blue | 8.6 | 20mg | 18.8mg | -5.8% | 97.30% | Lab G |
| 6 Jan 2026 | Sustanon 250 | 10.0 | 100mg/ml | 101.1mg/ml | +1.1% | 98.60% | Lab F |
| 6 Jan 2026 | Sustanon 250 | 9.1 | 250mg/ml | 268.1mg/ml | +7.2% | 99.23% | Lab B |
| 6 Jan 2026 | Test Suspension | 8.6 | 300mg/ml | 299.5mg/ml | -0.2% | 96.71% | Lab A |
| 6 Jan 2026 | Thymosin Alpha-1 | 8.7 | 2mg | 2.4mg | +21.8% | 96.38% | Lab C |
| 29 Dec 2025 | Adamax | 8.1 | 15mg | 15.4mg | +3.0% | 99.44% | Lab A |
| 29 Dec 2025 | Adipotide | 7.6 | 50mg | 61.6mg | +23.2% | 97.76% | Lab F |
| 29 Dec 2025 | BMK methyl glycidate CAS 80532-66-7 | 7.5 | 500g | 490.4g | -1.9% | 97.90% | Lab E |
| 29 Dec 2025 | Letrozole | 7.1 | 20mg | 17.7mg | -11.3% | 95.97% | Lab A |
| 29 Dec 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 7.9 | 5mg | 5.2mg | +4.4% | 99.17% | Lab B |
| 29 Dec 2025 | Sustanon 250 | 5.2 | 300mg/ml | 279.2mg/ml | -6.9% | 99.71% | Lab G |
| 29 Dec 2025 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 5.4 | 10mg | 10.1mg | +1.3% | 98.53% | Lab D |
| 12 Dec 2025 | AA Water | 6.1 | 15mg | 14.2mg | -5.6% | 99.84% | Lab C |
| 12 Dec 2025 | BMK methyl glycidate CAS 80532-66-7 | 8.1 | 500g | 484.8g | -3.0% | 95.75% | Lab D |
| 12 Dec 2025 | BMK methyl glycidate CAS 80532-66-7 | 9.5 | 1g | 1.1g | +9.9% | 97.27% | Lab A |
| 12 Dec 2025 | BMK methyl glycidate CAS 80532-66-7 | 7.6 | 100g | 85.1g | -14.9% | 97.98% | Lab F |
| 12 Dec 2025 | Estradiol Cypionate | 7.5 | 100mg/ml | 117.7mg/ml | +17.7% | 99.77% | Lab F |
| 12 Dec 2025 | Methylene Blue | 6.8 | 100mg | 120.2mg | +20.2% | 96.28% | Lab C |
| 12 Dec 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 7.2 | 20mg | 24.9mg | +24.4% | 97.63% | Lab D |
| 12 Dec 2025 | Phenylacetic acid CAS 103-82-2 | 6.8 | 5g | 5.0g | -1.0% | 98.36% | Lab E |
| 12 Dec 2025 | Phenylacetic acid CAS 103-82-2 | 5.1 | 500g | 525.4g | +5.1% | 99.89% | Lab A |
| 12 Dec 2025 | Prostamax | 6.2 | 10mg | 11.2mg | +11.8% | 98.67% | Lab C |
| 12 Dec 2025 | Prostamax | 5.3 | 2mg | 2.4mg | +19.1% | 99.34% | Lab G |
| 12 Dec 2025 | Tirzepatide Oral | 7.5 | 100mg | 92.4mg | -7.6% | 99.06% | Lab A |
| 12 Dec 2025 | Turinabol | 7.5 | 50mg | 61.5mg | +22.9% | 95.03% | Lab C |
| 5 Dec 2025 | Boldenone Cypionate | 8.2 | 100mg/ml | 123.7mg/ml | +23.7% | 95.83% | Lab C |
| 5 Dec 2025 | CJC-1295 With DAC | 8.6 | 5mg | 5.9mg | +18.9% | 96.52% | Lab F |
| 5 Dec 2025 | Crystagen | 8.4 | 30mg | 34.3mg | +14.2% | 99.39% | Lab B |
| 5 Dec 2025 | GHRP-6 Acetate | 5.9 | 20mg | 18.5mg | -7.6% | 97.11% | Lab G |
| 5 Dec 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 5.2 | 10mg | 10.3mg | +2.8% | 95.21% | Lab E |
| 5 Dec 2025 | Turinabol | 9.4 | 20mg | 20.9mg | +4.6% | 95.60% | Lab F |
| 23 Nov 2025 | AA Water | 7.4 | 15mg | 16.5mg | +10.1% | 96.74% | Lab E |
| 23 Nov 2025 | Adamax | 8.7 | 5mg | 5.1mg | +2.0% | 99.50% | Lab C |
| 23 Nov 2025 | BMK methyl glycidate CAS 80532-66-7 | 9.8 | 100g | 91.4g | -8.6% | 97.37% | Lab G |
| 23 Nov 2025 | Estradiol Cypionate | 9.9 | 250mg/ml | 252.0mg/ml | +0.8% | 96.64% | Lab A |
| 23 Nov 2025 | Ivermectin | 8.0 | 10mg | 12.2mg | +22.0% | 96.27% | Lab F |
| 23 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.8 | 2mg | 2.1mg | +4.2% | 97.62% | Lab G |
| 23 Nov 2025 | KPV | 5.8 | 15mg | 17.3mg | +15.5% | 97.60% | Lab D |
| 23 Nov 2025 | Letrozole | 5.6 | 25mg | 26.0mg | +4.0% | 98.60% | Lab G |
| 23 Nov 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.0 | 2mg | 2.1mg | +6.2% | 95.19% | Lab A |
| 23 Nov 2025 | Phenylacetic acid CAS 103-82-2 | 4.3 | 100g | 119.6g | +19.6% | 98.29% | Lab G |
| 23 Nov 2025 | Semaglutide Oral | 4.8 | 50mg | 59.9mg | +19.9% | 97.79% | Lab B |
| 17 Nov 2025 | Adipotide | 7.8 | 15mg | 17.0mg | +13.3% | 95.24% | Lab B |
| 17 Nov 2025 | BMK methyl glycidate CAS 80532-66-7 | 7.5 | 10g | 9.9g | -0.7% | 95.43% | Lab D |
| 17 Nov 2025 | CJC-1295 With DAC | 6.1 | 30mg | 30.9mg | +3.0% | 96.23% | Lab D |
| 17 Nov 2025 | Crystagen | 9.0 | 30mg | 35.1mg | +17.0% | 98.44% | Lab G |
| 17 Nov 2025 | Estradiol Cypionate | 6.5 | 100mg/ml | 123.2mg/ml | +23.2% | 97.50% | Lab C |
| 17 Nov 2025 | Estradiol Cypionate | 7.2 | 200mg/ml | 246.4mg/ml | +23.2% | 96.29% | Lab C |
| 17 Nov 2025 | HGH 191AA (Somatropin) | 8.5 | 2mg | 2.4mg | +17.6% | 96.68% | Lab E |
| 17 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 9.0 | 10mg | 11.5mg | +15.2% | 97.80% | Lab G |
| 17 Nov 2025 | Prostamax | 8.0 | 2mg | 2.3mg | +14.6% | 98.26% | Lab G |
| 17 Nov 2025 | Prostamax | 7.9 | 20mg | 18.6mg | -7.1% | 96.93% | Lab E |
| 17 Nov 2025 | Test Suspension | 7.5 | 250mg/ml | 246.6mg/ml | -1.4% | 97.40% | Lab F |
| 17 Nov 2025 | Turinabol | 8.3 | 50mg | 43.8mg | -12.4% | 99.34% | Lab B |
| 14 Nov 2025 | Aromasin (Exemestane) | 5.7 | 10mg | 11.5mg | +14.8% | 95.80% | Lab C |
| 14 Nov 2025 | Aromasin (Exemestane) | 8.8 | 20mg | 17.5mg | -12.7% | 95.09% | Lab A |
| 14 Nov 2025 | Aromasin (Exemestane) | 7.8 | 50mg | 51.6mg | +3.3% | 98.00% | Lab G |
| 14 Nov 2025 | Botulinum toxin | 8.8 | 30mg | 33.8mg | +12.6% | 97.45% | Lab D |
| 14 Nov 2025 | CJC-1295 With DAC | 7.1 | 2mg | 1.8mg | -10.5% | 98.16% | Lab A |
| 14 Nov 2025 | CJC-1295 With DAC | 6.9 | 2mg | 2.1mg | +3.7% | 98.28% | Lab G |
| 14 Nov 2025 | Crystagen | 6.8 | 5mg | 5.9mg | +18.7% | 96.40% | Lab C |
| 14 Nov 2025 | Crystagen | 6.0 | 20mg | 17.8mg | -11.1% | 98.37% | Lab D |
| 5 Nov 2025 | 5-amino-1MQ | 5.4 | 20mg | 23.6mg | +18.2% | 96.74% | Lab C |
| 5 Nov 2025 | 5-amino-1MQ | 6.9 | 5mg | 4.7mg | -6.3% | 99.44% | Lab A |
| 5 Nov 2025 | 5-amino-1MQ | 7.6 | 5mg | 5.9mg | +17.8% | 97.25% | Lab G |
| 5 Nov 2025 | AA Water | 4.8 | 50mg | 58.4mg | +16.8% | 98.15% | Lab C |
| 5 Nov 2025 | Adamax | 6.5 | 50mg | 50.9mg | +1.9% | 97.79% | Lab F |
| 5 Nov 2025 | Boldenone Cypionate | 8.3 | 300mg/ml | 267.6mg/ml | -10.8% | 95.86% | Lab D |
| 5 Nov 2025 | GHRP-6 Acetate | 7.6 | 20mg | 22.9mg | +14.5% | 96.54% | Lab D |
| 5 Nov 2025 | KPV Oral | 9.6 | 20mg | 21.3mg | +6.4% | 96.61% | Lab B |
| 5 Nov 2025 | Methylene Blue | 9.0 | 10mg | 9.1mg | -9.1% | 97.21% | Lab G |
| 5 Nov 2025 | Phenylacetic acid CAS 103-82-2 | 6.6 | 100g | 104.6g | +4.6% | 98.46% | Lab G |
| 5 Nov 2025 | Phenylacetic acid CAS 103-82-2 | 8.5 | 100g | 87.9g | -12.1% | 98.14% | Lab A |
| 5 Nov 2025 | Prostamax | 6.6 | 15mg | 14.0mg | -7.0% | 97.57% | Lab B |
| 4 Nov 2025 | 5-amino-1MQ | 7.7 | 2mg | 2.5mg | +24.8% | 99.63% | Lab F |
| 4 Nov 2025 | CJC-1295 With DAC | 8.5 | 10mg | 9.3mg | -7.5% | 97.61% | Lab C |
| 4 Nov 2025 | Estradiol Cypionate | 8.2 | 200mg/ml | 202.3mg/ml | +1.2% | 96.11% | Lab B |
| 4 Nov 2025 | Letrozole | 6.1 | 10mg | 12.0mg | +19.8% | 99.18% | Lab A |
| 4 Nov 2025 | Letrozole | 7.9 | 50mg | 46.3mg | -7.5% | 96.73% | Lab D |
| 4 Nov 2025 | Sustanon 250 | 6.8 | 100mg/ml | 114.2mg/ml | +14.2% | 98.63% | Lab B |
| 4 Nov 2025 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 4.9 | 5mg | 4.5mg | -10.3% | 95.38% | Lab C |
| 4 Nov 2025 | Turinabol | 8.1 | 100mg | 103.1mg | +3.1% | 97.53% | Lab A |
| 17 Oct 2025 | AA Water | 7.1 | 20mg | 18.3mg | -8.7% | 97.41% | Lab B |
| 17 Oct 2025 | Adamax | 7.7 | 15mg | 16.1mg | +7.2% | 97.36% | Lab B |
| 17 Oct 2025 | Adamax | 6.3 | 5mg | 6.2mg | +23.9% | 96.66% | Lab F |
| 17 Oct 2025 | Adipotide | 6.9 | 2mg | 1.7mg | -13.3% | 97.24% | Lab F |
| 17 Oct 2025 | BMK methyl glycidate CAS 80532-66-7 | 7.7 | 100g | 89.1g | -10.9% | 99.66% | Lab F |
| 17 Oct 2025 | Boldenone Cypionate | 5.8 | 100mg/ml | 110.7mg/ml | +10.7% | 97.86% | Lab D |
| 17 Oct 2025 | HGH Fragment 176-191 | 10.0 | 2mg | 2.1mg | +6.6% | 97.15% | Lab G |
| 17 Oct 2025 | Ivermectin | 8.1 | 20mg | 17.3mg | -13.6% | 95.59% | Lab F |
| 17 Oct 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 9.3 | 50mg | 44.5mg | -11.1% | 97.85% | Lab F |
| 17 Oct 2025 | Methylene Blue | 6.0 | 20mg | 20.5mg | +2.3% | 95.94% | Lab A |
| 17 Oct 2025 | Methylene Blue | 8.4 | 10mg | 8.9mg | -11.0% | 97.95% | Lab E |
| 17 Oct 2025 | Phenylacetic acid CAS 103-82-2 | 6.2 | 100g | 110.1g | +10.1% | 99.11% | Lab C |
| 9 Oct 2025 | Adamax | 5.5 | 10mg | 10.0mg | -0.5% | 98.13% | Lab F |
| 9 Oct 2025 | Adamax | 7.5 | 5mg | 5.6mg | +11.7% | 99.83% | Lab D |
| 9 Oct 2025 | Boldenone Cypionate | 7.7 | 100mg/ml | 85.6mg/ml | -14.4% | 98.59% | Lab B |
| 9 Oct 2025 | CJC-1295 With DAC | 8.8 | 20mg | 18.3mg | -8.5% | 96.81% | Lab E |
| 9 Oct 2025 | Estradiol Cypionate | 5.7 | 100mg/ml | 119.2mg/ml | +19.2% | 98.43% | Lab D |
| 9 Oct 2025 | Prostamax | 8.0 | 15mg | 16.0mg | +6.8% | 95.47% | Lab D |
| 3 Oct 2025 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 9.3 | 250mg/ml | 292.4mg/ml | +17.0% | 99.28% | Lab A |
| 3 Oct 2025 | HGH 191AA (Somatropin) | 10.0 | 10mg | 12.3mg | +23.4% | 99.21% | Lab F |
| 3 Oct 2025 | HGH Fragment 176-191 | 8.6 | 50mg | 50.5mg | +1.0% | 99.85% | Lab D |
| 3 Oct 2025 | Phenylacetic acid CAS 103-82-2 | 7.0 | 500g | 594.5g | +18.9% | 98.58% | Lab B |
| 3 Oct 2025 | Sustanon 250 | 8.1 | 250mg/ml | 239.8mg/ml | -4.1% | 97.11% | Lab C |
| 3 Oct 2025 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 5.8 | 5mg | 6.1mg | +22.3% | 95.04% | Lab G |